In cancer, BMP4 was shown to promote CSC differentiation, leading to diminished tumorigenic capacity and increased sensitivity to chemotherapy drugs in hepatocellular carcinoma and colorectal cancer models70,71. Here, BMP4 is linked to hepatocellular carcinoma.